Venus1-WTSTAT3
(Plasmid
#123164)
-
PurposeExpresses wild type STAT3 fused to the 1-157 fragment of Venus in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 123164 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA 3.3 Topo
-
Backbone manufacturerLife Technologies
- Backbone size w/o insert (bp) 5440
- Total vector size (bp) 8242
-
Modifications to backboneNone
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSTAT3 tagged with Venus1 (aa 1-157)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2802
-
Mutationnone
-
GenBank IDBC014482.1
-
Entrez GeneSTAT3 (a.k.a. ADMIO, ADMIO1, APRF, HIES)
- Promoter pCMV
-
Tag
/ Fusion Protein
- Venus1 (aa 1-158) for bimolecular fluorescence complementation assays (N terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer T7 (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Venus1-WTSTAT3 was a gift from Federico Herrera (Addgene plasmid # 123164 ; http://n2t.net/addgene:123164 ; RRID:Addgene_123164) -
For your References section:
Can asymmetric post-translational modifications regulate the behavior of STAT3 homodimers?. Letra-Vilela R, Cardoso B, Silva-Almeida C, Maia Rocha A, Murtinheira F, Branco-Santos J, Rodriguez C, Martin V, Santa-Marta M, Herrera F. FASEB Bioadv. 2020 Jan 27;2(2):116-125. doi: 10.1096/fba.2019-00049. eCollection 2020 Feb. 10.1096/fba.2019-00049 PubMed 32123861